AI Summary

MIT researchers have created an automated method for producing lipid nanoparticles, the fatty‑molecule carriers used in RNA vaccines and other nucleic‑acid therapies. The process runs without human intervention and allows precise control of particle size and shape. By accelerating nanoparticle fabrication, the technique could markedly shorten the timeline for developing new RNA and DNA therapeutics, according to the researchers.

AI summaries can be wrong sometimes—always verify important details using the source article.